TriLink - Accelerate mRNA Production with Maximum Efficiency

Category: Cell Therapy and Regenerative Medicine

Booth No: M330

Characteristic

TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap® mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine, diagnostic, NGS and CRISPR genome editing customers.

Notably, CleanCap technology offers many advantages over traditional enzymatic capping:
● GMP Grade Available
● 3x Transcriptional Yield
● One-Pot Synthesis for Superior Efficiency
● Reduces Immunogenicity
● Natural Cap 1 Structure

Integrated-Bio LTD. is the solo agent of TriLink BioTechnologies in Taiwan.